Evidence map›Paper›PMID 29311083›Full record

ArticleAntimicrobial agents and chemotherapy2018

Aspergillus fumigatus

Nanbiao Long, Liping Zeng, Shanlei Qiao, Lei Li, Guowei Zhong

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Loss of theMicrobiology spectrum · 2025
    Article
  2. Transcriptomic and metabolomic analysis of a non-Frontiers in microbiology · 2025
    Article
  3. Article
  4. Review
  5. Deletion ofAntimicrobial agents and chemotherapy · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Precise Expression ofmSphere · 2020
    Article
  10. Frontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nanbiao Long *Department of Laboratory Medicine, Shaoyang University, Shaoyang, China.
Liping Zeng *Department of Pathogen Biology, Nanjing Medical University, Nanjing, China.
Shanlei QiaoDepartment of Hygiene Analysis and Detection, School of Public Health, Nanjing Medical University, Nanjing, China.
Lei LiDepartment of Hygiene Analysis and Detection, School of Public Health, Nanjing Medical University, Nanjing, China.
Guowei Zhong *Department of Hygiene Analysis and Detection, School of Public Health, Nanjing Medical University, Nanjing, China zgwmvp@163.com.
Nanjing Medical University · CNShaoyang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antifungal treatment is often ineffectual, partly because of biofilm formation. In this study, by using a combined forward and reverse genetic strategy, we identified that nucleus-localized AfSsn3 and its partner AfSsn8, which constitute a Cdk8-cyclin pair, are required for azole resistance in

Indexed as

Antifungal AgentsAspergillus fumigatusAzolesBiofilmsDrug Resistance, FungalFungal ProteinsMicrobial Sensitivity TestsPolysaccharidesSphingolipidsAntifungal AgentsAzolesFungal ProteinsPolysaccharidesSphingolipidsAfssn3Aspergillus fumigatusbiofilmefflux pumpextracellular polysaccharidesphingolipid pathway intermediates

Identifiers

PMID29311083
PMCPMC5826118
OpenAlexW2781624539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.